Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren

Smx2.8

Semax – Forschung

Überwiegend Mechanismus / Beobachtung

12 begutachtete Studien

Was die Evidenz sagt

Überwiegend Mechanismus / Beobachtung

Die meisten Studien zu Semax sind mechanistisch oder beobachtend statt RCTs, die einen klinischen Effekt messen — betrachte die Ergebnisse als vorläufig.

Die meiste Evidenz stammt aus gemischt-qualitativen randomisierten Studien, veröffentlicht 2005–2025 mit einer typischen Studiengröße von 52 Teilnehmenden.

Basierend auf 12 Studien · 1 RCT · 186 Teilnehmende insgesamt

Konfidenz

Geringe Konfidenz

Nach Outcome

Stroke & neuroprotectionIn einer russischen offenen Studie mit 110 Patienten erhöhte intranasales Semax zusätzlich zur Schlaganfall-Rehabilitation das Plasma-BDNF und verbesserte die funktionelle Erholung; präklinische Arbeiten zeigen eine Neurotrophin-Induktion und einen neuronalen Schutz · Über Wochen der Behandlung (kleine Studien)
Überwiegend Mechanismus / Beobachtung7 Studien
Cognitive functionWird für Gedächtnis und Aufmerksamkeit vermarktet und eingesetzt; eine russische offene Studie mit 110 Patienten berichtete über erhöhtes BDNF und verbesserte funktionelle Erholung zusätzlich zur Rehabilitation, wenngleich eine unabhängige Replikation spärlich ist · Tage bis Wochen (kleine Studien)
Überwiegend Mechanismus / Beobachtung5 Studien

Stetige Forschung

2 Studien in den letzten 5 Jahren

200520152025

1RCT2007

Serdiuk AV, Levitskiĭ GN, Miasoedov NF, Skvortsova VI · Zh Nevrol Psikhiatr Im S S Korsakova (2007)

2Tierstudie2025

Einfach gesagt: Semax promoted SCI functional recovery by targeting μ-opioid receptors, which regulated USP18 and, subsequently, deubiquitination of the fat mass and obesity-associated protein (FTO), suggesting its potential for SCI treatment.

Liu R, Chen Y, Huang H, Li X, Lv J, Jiang L, Jiang H, Wu C. · Br J Pharmacol (2025)

Mouse spinal-cord-injury (SCI) model plus PC12 neuroinflammation model — an independent (Chinese) group, not the originating Russian labs
Semax improved functional recovery (Basso scores, footprint, inclined-plane) and inhibited lysosomal-permeabilization-related pyroptosis by reducing oxidative stress
RNA-seq, network pharmacology and docking implicated the μ-opioid receptor and the deubiquitinase USP18 as targets/effectors

Quelle ansehen

3Tierstudie2006

Einfach gesagt: These findings indicate that the cognitive effects exerted by Semax might be associated, at least in part, with increased BDNF protein levels in this brain region.

Dolotov OV, Karpenko EA, Seredenina TS, Inozemtseva LS, Levitskaya NG, Zolotarev YA. · J Neurochem (2006)

Rat study; intranasal Semax (50 and 250 microg/kg) rapidly increased BDNF levels in the basal forebrain after 3 h, but not in the cerebellum
Identified specific, reversible, calcium-dependent binding sites for tritiated Semax in basal-forebrain membranes (KD ~2.4 nM)
Links the proposed cognitive action to regional BDNF induction and a specific binding site

Quelle ansehen

4Tierstudie2005

Einfach gesagt: Our results reveal the positive modulatory effect of Semax on the striatal serotonergic system and the ability of Semax to enhance both the striatal release of dopamine and locomotor behavior elicited by D-amphetamine.

Eremin KO, Kudrin VS, Saransaari P, Oja SS, Grivennikov IA, Myasoedov NF, Rayevsky KS. · Neurochem Res (2005)

Rodent neurochemistry study; Semax increased striatal 5-HIAA tissue content (+25%) and raised extracellular 5-HIAA up to 180% over 1-4 h
Semax alone did not change dopamine or its metabolites, but markedly enhanced amphetamine-evoked extracellular dopamine and locomotion
Implicates melanocortin-monoamine cross-talk in Semax's 'nootropic'/arousal effects

Quelle ansehen

5Tierstudie2006

Einfach gesagt: We suggest that Semax affects cognitive brain functions by modulating the expression and the activation of the hippocampal BDNF/trkB system.

Dolotov OV, Karpenko EA, Inozemtseva LS, Seredenina TS, Levitskaya NG, Rozyczka J. · Brain Res (2006)

Rat study; a single 50 microg/kg dose of Semax increased hippocampal BDNF protein (~1.4-fold) and trkB tyrosine phosphorylation (~1.6-fold)
Raised exon-III BDNF mRNA (~3-fold) and trkB mRNA (~2-fold) in the hippocampus
Semax-treated rats showed a distinct increase in conditioned avoidance reactions (a learning measure)

Quelle ansehen

6In vitro2008

Einfach gesagt: We have shown that Semax may approximately 1.5-1.7 fold increase survival of cholinergic basal forebrain neurons in vitro.

Grivennikov IA, Dolotov OV, Zolotarev YA, Andreeva LA, Myasoedov NF, Leacher L, Black IB, Dreyfus CF. · Restor Neurol Neurosci (2008)

In-vitro study of rat basal-forebrain neuronal/glial cultures
Semax increased survival of cholinergic basal-forebrain neurons ~1.5-1.7 fold and stimulated choline acetyltransferase activity
Did not affect GABAergic neurons or glial proliferation

7Tierstudie2010

Einfach gesagt: We have shown for the first time that both Semax and PGP activate the transcription of neurotrophins and their receptors in the cortex of rats subjected to pMCAO.

Dmitrieva VG, Povarova OV, Skvortsova VI, Limborska SA, Myasoedov NF, Dergunova LV. · Cell Mol Neurobiol (2010)

Rat permanent middle-cerebral-artery-occlusion (pMCAO) stroke model; gene expression measured at 3, 24 and 72 h
Semax enhanced transcription of Bdnf, TrkC and TrkA at 3 h and Nt-3/Ngf later, selectively in ischemic cortex
The PGP fragment's effects were largely non-specific by comparison

Quelle ansehen

8In vitro2007

Einfach gesagt: The neuroprotective effect of semax in cerebral ischemia/hypoxia can be due to improvement of mitochondrial resistance to 'calcium' stress.

Storozhevykh TP, Tukhbatova GR, Senilova YE, Pinelis VG, Andreeva LA, Myasoyedov NF. · Bull Exp Biol Med (2007)

In-vitro study in cultured cerebellar granule cells under glutamate excitotoxicity
Semax (100 microM) and its PGP fragment delayed calcium dysregulation and loss of mitochondrial potential
Improved neuronal survival by ~30% on average

Quelle ansehen

9Übersicht2024

Einfach gesagt: The review of clinical studies indicates that MGHPPGP is clinically effective in the treatment of ischemic stroke both in the acute period of stroke and in the recovery period.

Spirin NN, Fedorov VN, Vdovichenko VP. · Zh Nevrol Psikhiatr Im S S Korsakova (2024)

Russian review of clinical studies of intranasal Semax (MGHPPGP) in ischemic stroke
Reports clinical efficacy in both the acute and recovery periods of stroke, framing the intranasal route as a way around the closed 'therapeutic window'
Reports efficacy across atherothrombotic and cardioembolic subtypes and both carotid and vertebrobasilar territories

Quelle ansehen

10Open-Labeln=110 · medium study2018

Einfach gesagt: Early rehabilitation and administration of semax increase BDNF plasma level, speed functional recovery, and improve motor performance.

Gusev EI, Martynov MY, Kostenko EV, Petrova LV, Bobyreva SN. · Zh Nevrol Psikhiatr Im S S Korsakova (2018)

110 patients after ischemic stroke, divided into early/late rehabilitation groups with semax+ and semax- subgroups; standard regimen 6000 mcg/day intranasally in two 10-day courses
Semax raised and sustained plasma BDNF levels regardless of rehabilitation timing
Semax and high BDNF accelerated and improved final Barthel-index recovery, with a positive BDNF-Barthel correlation

Quelle ansehen

11Open-Labeln=52 · small study2020

Einfach gesagt: Post hoc analysis allowed us to define both general and specific effects of Selank and Semax on FC between the right amygdala and the right temporal cortex for the first time.

Panikratova YR, Lebedeva IS, Sokolov OY, Rumshiskaya AD, Kupriyanov DA, Kost NV, Myasoedov NF. · Dokl Biol Sci (2020)

Resting-state fMRI in 52 healthy participants, comparing Semax, Selank and placebo before and 5/20 min after injection
Examined whole-brain functional connectivity of amygdala and dorsolateral prefrontal cortex regions of interest
Found between-group and between-condition differences in connectivity between the right amygdala and right temporal cortex

Quelle ansehen

12Open-Labeln=24 · very small study2018

Einfach gesagt: A greater volume of the default mode network rostral (medial frontal cortex) subcomponent was detected in the Semax group in comparison with controls.

Lebedeva IS, Panikratova YR, Sokolov OY, Kupriyanov DA, Rumshiskaya AD, Kost NV, Myasoedov NF. · Bull Exp Biol Med (2018)

Resting-state fMRI in healthy volunteers (24 subjects), 3 scans before and 5/20 min after intranasal 1% Semax (14) or placebo (10)
Studied the topography of the default mode network
Found a greater volume of the rostral (medial frontal cortex) default-mode subcomponent in the Semax group

Quelle ansehen

In der Forschungsbibliothek ansehen

Semax – Forschung

Überwiegend Mechanismus / Beobachtung

[The study of chronic partial denervation and quality of life in patients with motor neuron disease treated with semax].

Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice.

Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain.

Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.

Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.

Effects of behaviorally active ACTH (4-10) analogue - Semax on rat basal forebrain cholinergic neurons.

Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia.

Effects of semax and its Pro-Gly-Pro fragment on calcium homeostasis of neurons and their survival under conditions of glutamate toxicity.

[Place of oligopeptide H-Met-Glu-His-Phe-Pro-Gly-Pro-OH in the therapy and rehabilitation of patients with ischemic stroke].

[The efficacy of semax in the treatment of patients at different stages of ischemic stroke].

Functional Connectomic Approach to Studying Selank and Semax Effects.

Effects of Semax on the Default Mode Network of the Brain.